Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Form 4 Filing
CFO of Fulgent Genetics, Paul Kim, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 3, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., had 1,412 shares of common stock withheld to satisfy tax obligations.
- This withholding was related to the vesting of restricted stock units granted on August 3, 2020.
- Following the transaction, Kim directly owns 211,888 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of compliance for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard tax withholding procedure.
Key Dates
| Date | Description |
|---|---|
| August 3, 2020 | Date of original grant of restricted stock units. |
| August 5, 2020 | Date Form 4 was filed with the U.S. Securities and Exchange Commission regarding the grant of restricted stock units. |
| August 3, 2024 | Date of the reported transaction (tax withholding). |
| August 6, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.